{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:16:56Z","timestamp":1781619416006,"version":"3.54.5"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:00:00Z","timestamp":1763769600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T00:00:00Z","timestamp":1766966400000},"content-version":"vor","delay-in-days":37,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Cat scratch disease (CSD) is the commonest etiology of neuroretinitis (NR) and is caused by\n                      <jats:italic>Bartonella henselae<\/jats:italic>\n                      . The objective of this study was to look at clinical, imaging characteristics and outcomes among serology confirmed Cat scratch disease Neuroretinitis (CSD NR).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective review of clinical records of 33 eyes from 28 patients was undertaken over a 5-year period between April 2015 and February 2020.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean age at presentation was 34.3 years. Twenty-two (78.6%) had contact with cat. Mean duration of ocular symptoms was 7.0 days. Eighteen (64.3%) had history of fever while 24 (85.7%) complained of blurring of vision. Median baseline logMAR visual acuity was 0.8 (0.2-2.00) and median final logMAR VA was 0.2 (0.00-1.8),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.01. Anterior segment inflammation was absent (57.6%) or mild (36.4%). An inflammatory angiomatous optic nerve head lesion was present in 9 (27.3%) eyes. Seventeen (51.5%) eyes had retinal infiltrates or focal retino-choroiditis. This was seen in 66.7% eyes presenting within a week and was absent in 77.8% presenting after a week (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.034). Eight (24.2%) eyes had no macula exudates at presentation out of which 7 had peripapillary subretinal fluid (SRF) on optical coherence tomography (OCT). Median baseline oct central subfoveal thickness (CST) was 303\u00a0\u03bcm (213\u20131159) and median final CST was 262\u00a0\u03bcm (193\u2013344),\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001. Hyperreflective vitreous dots on OCT were present in 16 (50.0%) with no clinical evidence of vitritis or vitreous cells in 18.75%. Peripapillary SRF was seen in 26 (81.3%), subfoveal SRF in 23 (71.9%), macula intraretinal fluid (IRF) in 12 (37.5%) and abnormal foveal contour in 22 (68.8%). Fluorescein angiography showed disc leakage in 10 out of 15 eyes (66.7%). All patients received treatment, 17(60.7%) with oral antibiotics and 11 (39.3%) with additional oral steroids.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Presenting visual acuity was moderate to poor with good final visual outcomes. Severe anterior uveitis was uncommon. Absence of baseline macular exudates maybe associated with peripapillary subretinal fluid. Retinal infiltrates or focal retino-choroiditis were common but seen early in presentation. Hyperreflective dots in the vitreous on OCT may precede clinical visualization of vitreous involvement. Significant reduction in CST on OCT was seen at six weeks.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12348-025-00539-w","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T08:23:38Z","timestamp":1763799818000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical and imaging characteristics of neuroretinitis secondary to cat scratch disease from tertiary centers in Malaysia: a retrospective study"],"prefix":"10.1186","volume":"15","author":[{"given":"Rajasudha Sawri","family":"Rajan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangeeta","family":"Kuganasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazima Shadaht","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roslin Azni Abdul","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelina Oli","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,22]]},"reference":[{"issue":"5","key":"539_CR1","first-page":"763","volume":"83","author":"JD Gass","year":"1977","unstructured":"Gass JD (1977) Diseases of the optic nerve that May simulate macular disease. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol. 83(5):763\u2013770","journal-title":"Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol."},{"issue":"1","key":"539_CR2","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1097\/00004397-200101000-00009","volume":"41","author":"S Ray","year":"2001","unstructured":"Ray S, Gragoudas E (2001) Neuroretinitis. Int Ophthalmol Clin 41(1):83\u2013102. https:\/\/doi.org\/10.1097\/00004397-200101000-00009","journal-title":"Int Ophthalmol Clin"},{"issue":"4","key":"539_CR3","doi-asserted-by":"publisher","first-page":"e524","DOI":"10.1111\/aos.13684","volume":"96","author":"Z Habot-Wilner","year":"2018","unstructured":"Habot-Wilner Z, Trivizki O, Goldstein M, Kesler A, Shulman S, Horowitz J, Amer R, David R, Ben-Arie-Weintrob Y, Bakshi E, Almog Y, Sartani G, Vishnevskia-Dai V, Kramer M, Bar A, Kehat R, Ephros M, Giladi M (2018) Cat-scratch disease: ocular manifestations and treatment outcome. Acta Ophthalmol 96(4):e524\u2013e532","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"539_CR4","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/S0161-6420(00)00002-6","volume":"107","author":"EB Suhler","year":"2000","unstructured":"Suhler EB, Lauer AK, Rosenbaum JT (2000) Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology 107(5):871\u2013876","journal-title":"Ophthalmology"},{"issue":"6","key":"539_CR5","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3109\/01658107.2015.1092561","volume":"39","author":"R Kahloun","year":"2015","unstructured":"Kahloun R, Khairallah-Ksiaa I, Abroug N, Mahmoud A, Ben Yahia S, Zaouali S, Jelliti B, Khairallah M (2015) Final diagnosis in patients referred with a diagnosis of neuroretinitis. Neuroophthalmology 39(6):266\u2013270","journal-title":"Neuroophthalmology"},{"issue":"8","key":"539_CR6","first-page":"375","volume":"87","author":"R Debre","year":"1950","unstructured":"Debre R (1950) La maladie des Griffes du chat [Cat scratch disease]. Mars Med 87(8):375\u2013UndeterminedLanguage PMID: 14842248","journal-title":"Mars Med"},{"key":"539_CR7","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/5584_2017_19","volume":"1020","author":"J Brydak-Godowska","year":"2017","unstructured":"Brydak-Godowska J, Kopacz D, Borkowski PK, Fiecek B, Hevelke A, Rabczenko D, Tylewska-Wierzbanowska S, K\u0119cik D, Chmielewski T (2017) Seroprevalence of Bartonella species in patients with ocular inflammation. Adv Exp Med Biol 1020:33\u201342 doi: 10.1007\/5584_2017_19. PMID: 28405890","journal-title":"Adv Exp Med Biol"},{"issue":"3","key":"539_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.joco.2019.03.005","volume":"31","author":"I Ksiaa","year":"2019","unstructured":"Ksiaa I, Abroug N, Mahmoud A, Zina S, Hedayatfar A, Attia S, Khochtali S, Khairallah M (2019) Update on bartonella neuroretinitis. J Curr Ophthalmol 31(3):254\u2013261. https:\/\/doi.org\/10.1016\/j.joco.2019.03.005","journal-title":"J Curr Ophthalmol"},{"issue":"2","key":"539_CR9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.3109\/09273948.2013.833631","volume":"22","author":"AL Biancardi","year":"2014","unstructured":"Biancardi AL, Curi AL (2014) Cat-scratch disease. Ocul Immunol Inflamm 22(2):148\u2013154. https:\/\/doi.org\/10.3109\/09273948.2013.833631","journal-title":"Ocul Immunol Inflamm"},{"key":"539_CR10","doi-asserted-by":"publisher","unstructured":"Angelakis E, Raoult D. Pathogenicity and treatment of Bartonella infections. Int J Antimicrob Agents. 2014;44(1):16\u201325. https:\/\/doi.org\/10.1016\/j.ijantimicag.2014.04.006 . Epub 2014 May 9. PMID: 24933445","DOI":"10.1016\/j.ijantimicag.2014.04.006"},{"key":"539_CR11","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1097\/IAE.0000000000000793","volume":"36","author":"PC Parikh","year":"2016","unstructured":"Parikh PC, Brucker AJ, Tamhankar MA (2016) An atypical presentation of Bartonella neuroretinitis. Retina. 36:e18-19","journal-title":"Retina."},{"key":"539_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.7883\/yoken.JJID.2017.518","volume":"71","author":"C Hande","year":"2018","unstructured":"Hande C, Haluk K, Muhsin E et al (2018) Bartonella hensalae neuroretinitis in patients without Cat scratch. Jpn J Infect Dis 71:397\u2013401. https:\/\/doi.org\/10.7883\/yoken.JJID.2017.518","journal-title":"Jpn J Infect Dis"},{"key":"539_CR13","first-page":"311","volume":"10","author":"S-YT Michele","year":"2020","unstructured":"Michele S-YT, Gayathri G, Francesca MV (2020) The clinical spectrum of ocular bartonellosis: a retrospective study at a tertiary centre in Malaysia. J Oph Infl Infect 10:311\u2013310","journal-title":"J Oph Infl Infect"},{"issue":"1","key":"539_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1097\/WNO.0b013e31820cf78a","volume":"31","author":"V Purvin","year":"2011","unstructured":"Purvin V, Sundaram SK (2011) Neuroretinitis: review of the literature and new observations. J Neuro-Ophthalmol 31(1):58\u201368","journal-title":"J Neuro-Ophthalmol"},{"key":"539_CR15","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.2105\/AJPH.83.12.1707","volume":"83","author":"LA Jackson","year":"1993","unstructured":"Jackson LA, Perkins BA, Wenger JD (1993) Cat scratch disease in the United States: an analysis of three National databases. Am J Public Health 83:1707\u20131711","journal-title":"Am J Public Health"},{"key":"539_CR16","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1097\/ICU.0000000000000419","volume":"28","author":"A Radgonde","year":"2017","unstructured":"Radgonde A, Ilknur TT (2017) Ophthalmic manifestations of Bartonella infection. Curr Opin Ophthalmol 28:607\u2013612","journal-title":"Curr Opin Ophthalmol"},{"key":"539_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ophtha.2011.06.042","volume":"119","author":"SL Chi","year":"2012","unstructured":"Chi SL, Stinnett S, Eggenberger E (2012) Clinical characteristics in 53 patients with cat scratch optic neuropathy. Ophthalmology 119:183\u2013187","journal-title":"Ophthalmology"},{"key":"539_CR18","first-page":"1","volume":"0","author":"JL Christian","year":"2020","unstructured":"Christian JL (2020) Neuroretinitis: a tricky mimic. Pract Neurol 0:1\u20133","journal-title":"Pract Neurol"},{"issue":"2","key":"539_CR19","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/s41433-024-03466-7","volume":"39","author":"S Jane","year":"2025","unstructured":"Jane S, Helen VDM, MT Bhatti (2025) Neuroretinitis: a comprehensive review on aetiologies, clinical manifestations, and treatment options. Eye (Lond) 39(2):238\u2013250","journal-title":"Eye (Lond)"},{"key":"539_CR20","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0161-6420(98)93028-7","volume":"105","author":"JB Reed","year":"1998","unstructured":"Reed JB, Scales DK, Wong MT et al (1998) Bartonella Henselae neuroretinitis in Cat scratch disease. Diagnosis, Management, and sequalae. Ophthalmology 105:459\u2013466","journal-title":"Ophthalmology"},{"key":"539_CR21","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev.micro.58.030603.123700","volume":"58","author":"C Dehio","year":"2004","unstructured":"Dehio C (2004) Molecular and cellular basis of Bartonella pathogenesis. Annu Rev Microbiol 58:365\u2013390","journal-title":"Annu Rev Microbiol"},{"issue":"8","key":"539_CR22","doi-asserted-by":"publisher","first-page":"1546","DOI":"10.1016\/S0161-6420(99)90452-9","volume":"106","author":"WA Solley","year":"1999","unstructured":"Solley WA, Martin DF, Newman NJ (1999) Cat scratch disease: posterior segment manifestations. Ophthalmology 106(8):1546\u20131553","journal-title":"Ophthalmology"},{"key":"539_CR23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s10792-010-9389-5","volume":"30","author":"AL Curi","year":"2010","unstructured":"Curi AL, Machado D, Heringer G et al (2010) Cat-scratch disease: ocular manifestations and visual outcome. Int Ophthalmol 30:553\u2013558","journal-title":"Int Ophthalmol"},{"issue":"4","key":"539_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1128\/CDLI.5.4.486-490.1998","volume":"5","author":"A Sander","year":"1998","unstructured":"Sander A, Posselt M, Oberle K, Bredt W (1998) Seroprevalence of antibodies to Bartonella Henselae in patients with Cat scratch disease and in healthy controls: evaluation and comparison of two commercial serological tests. Clin Diagn Lab Immunol 5(4):486\u2013490 PMID: 9665953; PMCID: PMC95604","journal-title":"Clin Diagn Lab Immunol"},{"key":"539_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-023-16276-5","volume":"23","author":"SMI Munir","year":"2023","unstructured":"Munir SMI, Mokhtar MI, Arham AF (2023) Public perspectives on strays and companion animal management in Malaysia. BMC Public Health 23:1428. https:\/\/doi.org\/10.1186\/s12889-023-16276-5","journal-title":"BMC Public Health"},{"key":"539_CR26","doi-asserted-by":"publisher","unstructured":"Chai LT, Lai CF, Evelyn LMT et al. Clinical profile and visual outcome of ocular bartonellosis in Malaysia. J Trop Med 1. 2017. https:\/\/doi.org\/10.1155\/2017\/7946123","DOI":"10.1155\/2017\/7946123"},{"key":"539_CR27","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/eye.2011.125","volume":"25","author":"Z Habot-Wilner","year":"2011","unstructured":"Habot-Wilner Z, Zur D, Goldstein M et al (2011) Macular findings on optical coherence tomography in cat-scratch disease neuroretinitis. Eye 25:1064\u20131068","journal-title":"Eye"},{"issue":"3","key":"539_CR28","first-page":"327","volume":"130","author":"NW Kevin","year":"2000","unstructured":"Kevin NW, Matthew RJ, Robert B et al (2000) Optic disk edema associated with peripapillary serous retinal detachment: an early sign of systemic Bartonella Henselae infection. AJO Sept 130(3):327\u2013334","journal-title":"AJO Sept"},{"key":"539_CR29","unstructured":"The Standardization of Uveitis Nomenclature (SUN) Working group. Standardization of Uveitis Nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol (2005) September ; 140(3): 509\u2013516"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00539-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-025-00539-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00539-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:23:49Z","timestamp":1781616229000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12348-025-00539-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,22]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["539"],"URL":"https:\/\/doi.org\/10.1186\/s12348-025-00539-w","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,22]]},"assertion":[{"value":"23 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study is registered with the National Medical Research Registry with the identification number: NMRR ID-24-02740-7WK. Ethics approval was obtained from the Medical Research and Ethics Committee (MREC). Consent for publication was obtained from the institute and from the individuals for the cases shared under Figs.\u00a01 and 2.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"96"}}